drugset / Trial / NCT00174447
Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Open label extension study of Ziprasidone, evaluation of safety of long term use of ziprasidone
Timeline
- Start
- 2001-10
- Primary completion
- 2008-10
- Completion
- 2008-10
Publications
- Geier JL, Karayal ON, Lewis M, Camm JA, Keane M, Kremer CM, Kolluri S, Reynolds R, Eng S, Strom BL. Methodological challenges in the coding and adjudication of sudden deaths in a large simple trial with observational follow-up: the ziprasidone observational study of cardiac outcomes (ZODIAC). Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1192-8. doi: 10.1002/pds.2185. Epub 2011 Jul 27.
- Strom BL, Faich GA, Reynolds RF, Eng SM, D'Agostino RB, Ruskin JN, Kane JM. The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC): design and baseline subject characteristics. J Clin Psychiatry. 2008 Jan;69(1):114-21. doi: 10.4088/jcp.v69n0115.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ziprasidone | Small molecule | 40 mg | Oral |
| Subject | Ziprasidone | Small molecule | 60 mg | Oral |
| Subject | Ziprasidone | Small molecule | 80 mg | Oral |